DaraDHolderMD

PubMed

• 17 citations
  A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guérin Unresponsive or Recurrent/Relap...
  Guarionex Joel DeCastro, Wilson Sui, Jamie S. Pak, Shing M. Lee, Dara Holder, Max M. Kates, Renu K. Virk, Charles G. Drake, Christopher B. Anderson, Bridget James, Cor...> ;The Journal of Urology. 2020 Mar 2
• 54 citations
  Phase II Trial of Intravesical Nanoparticle Albumin Bound Paclitaxel for the Treatment of Nonmuscle Invasive Urothelial Carcinoma of the Bladder after bacillus Calmett...
  James M. McKiernan, Dara Holder, Rashed Ghandour, LaMont J. Barlow, Jennifer Ahn, Max Kates, Gina M. Badalato, Arindam RoyChoudhury, G. Joel DeCastro, Mitchell C. Benson> ;The Journal of Urology. 2014 Dec 1
• 8 citations
  The role of preoperative prostatic urethral biopsy in clinical decision-making at the time of radical cystectomy.
  Josep M. Gaya, Justin T. Matulay, Gina M. Badalato, Dara Holder, Gregory W. Hruby, James M. McKiernan> ;The Canadian Journal of Urology. 2014 Apr 1
• 5 citations
  The role of pelvic lymphadenectomy in non-muscle invasive bladder cancer.
  James Lin, Christopher M. Deibert, Dara Holder, Mitchell C. Benson, James M. McKiernan> ;The Canadian Journal of Urology. 2014 Feb 1
• 8 citations
  Neoadjuvant chemotherapy in the treatment of muscle invasive bladder cancer with mixed histology.
  James Lin, Michael J. Whalen, Dara Holder, Gregory W. Hruby, G. Joel DeCastro, James M. McKiernan> ;The Canadian Journal of Urology. 2013 Apr 1
• Join now to see all

Journal Articles

• Phase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of non-muscle invasive urothelial carcinoma of the bladder after bacillus Calmet...  
  McKiernan JM, Holder DD, Ghandour RA, Barlow LJ, Ahn JJ, Kates M, Badalato GM, Roychoudhury A, Decastro GJ, Benson MC, J Urol, 1/1/2014
• Neoadjuvant chemotherapy in the treatment of muscle invasive bladder cancer with mixed histology  
  Lin J, Whalen M, Holder D, Hruby G, Decastro GJ, McKiernan J, Can J Urol, 1/1/2013
• High expression of the PAX3-FKHR oncoprotein is required to promote tumorigenesis of human myoblasts  
  Xia SJ, Holder DD, Pawel BR, Zhang C, Barr FG, American Journal of Pathology, 1/1/2009

Abstracts/Posters

• Prognostic Effect of a Re-TURBT prior to neoadjuvant chemotherapy for urothelial carcinoma of the bladder
  Dara D. Holder, Josep Gaya, Greg Hruby, Mitchell Benson, Daniel Petrylak, G. Joel DeCastro, James McKiernan, World Congress of Endourology, Istanbul, Turkey, 1/1/2012
• Updated Results of the combined phase I/II trial of Intravesical nanoparticle albumin bound paclitaxel in the treatment of BCG refractory non-muscle invasive transitio...
  James M. McKiernan, Dara D. Holder, American Urologic Association, Atlanta, GA, 1/1/2012
• Identification of a Predictive factor for response to neoadjuvant chemotherapy in urothelial carcinoma
  Dara D. Holder, Josep Gaya, G. Joel DeCastro, James M. McKiernan, Eastern Atlantic Student Research Forum, University of Miami, Miami, FL, 1/1/2012
• The role of MYCN in Alveolar Rhabdomyosarcoma tumorigenesis
  Dara D. Holder, Frederic Barr MD PHD, Department of Biochemistry Senior Research Symposium, University of Pennsylvania, Philadelphia, PA, 1/1/2008
• Join now to see all

Lectures

• Phase II trial of intravesical nano-particle albumin – bound paclitaxel for the treatment of non-muscle invasive urothelial carcinoma after BCG failure 
  San Diego, CA - 1/1/2013
• Therapeutic effect of a Re-TURBT prior to Neoadjuvant chemotherapy for urothelial carcinoma of the bladder 
  New York, NY - 1/1/2012
• Repeat Transurethral resection prior to neoadjuvant chemotherapy for urothelial carcinoma of the bladder 
  New York, NY - 1/1/2012
• Evaluating Efficacy: “Trends in Breast Cancer staging at the Breast Examination Center of Harlem [BECH] over 13 years” 
  Memorial Sloan Kettering Cancer Center, New York, NY - 1/1/2009
• HIV/AIDS and Assumptions: Case manager’s influence on the dissemination of HIV prevention to their seriously mentally ill clients 
  Leonard Davis Institute for Health Economics, University of Pennsylvania - 1/1/2007
• Join now to see all